Symbols / EWTX Stock $32.17 -0.86% Edgewise Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
EWTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 3.45B Enterprise Value Income Sales Book/sh Cash/sh
Dividend Yield Payout Employees IPO P/E Forward P/E
PEG P/S P/B P/C EV/EBITDA EV/Sales
Quick Ratio Current Ratio Debt/Eq LT Debt/Eq EPS (ttm) EPS next Y
EPS Growth Revenue Growth Earnings ROA ROE ROIC
Gross Margin Oper. Margin Profit Margin Shs Outstand Shs Float Short Float
Short Ratio Short Interest 52W High 52W Low Beta Avg Volume
Volume Target Price Recom Prev Close $32.45 Price $32.17 Change -0.86%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
Simplified FCF or EPS-based estimate
Ratings
Current target
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
191.41
+20.51%
158.83
+38.89%
114.36
+59.59%
71.66
Research And Development
151.39
+19.24%
126.97
+39.67%
90.91
+68.24%
54.03
Selling General And Administration
40.02
+25.58%
31.87
+35.88%
23.45
+33.05%
17.63
General And Administrative Expense
40.02
+25.58%
31.87
+35.88%
23.45
+33.05%
17.63
Other Gand A
40.02
+25.58%
31.87
+35.88%
23.45
+33.05%
17.63
Total Expenses
191.41
+20.51%
158.83
+38.89%
114.36
+59.59%
71.66
Operating Income
-191.41
-20.51%
-158.83
-38.89%
-114.36
-59.59%
-71.66
Total Operating Income As Reported
-191.41
-20.51%
-158.83
-38.89%
-114.36
-59.59%
-71.66
EBITDA
-189.14
-20.82%
-156.54
-38.99%
-112.62
-58.36%
-71.12
Normalized EBITDA
-189.14
-20.82%
-156.54
-38.99%
-112.62
-58.36%
-71.12
Reconciled Depreciation
2.27
-1.05%
2.29
+32.22%
1.73
+221.93%
0.54
EBIT
-191.41
-20.51%
-158.83
-38.89%
-114.36
-59.59%
-71.66
Net Income
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Pretax Income
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Net Non Operating Interest Income Expense
23.61
-5.63%
25.02
+76.26%
14.19
+253.26%
4.02
Net Interest Income
23.61
-5.63%
25.02
+76.26%
14.19
+253.26%
4.02
Interest Income Non Operating
23.61
-5.63%
25.02
+76.26%
14.19
+253.26%
4.02
Interest Income
23.61
-5.63%
25.02
+76.26%
14.19
+253.26%
4.02
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Net Income From Continuing Operation Net Minority Interest
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Net Income From Continuing And Discontinued Operation
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Net Income Continuous Operations
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Normalized Income
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Net Income Common Stockholders
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Diluted EPS
-0.42
+73.25%
-1.57
-406.45%
-0.31
Basic EPS
-0.42
+73.25%
-1.57
-406.45%
-0.31
Basic Average Shares
94.72
+48.64%
63.72
+0.78%
63.23
Diluted Average Shares
94.72
+48.64%
63.72
+0.78%
63.23
Diluted NI Availto Com Stockholders
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
552.60
+13.51%
486.82
+43.17%
340.04
-7.37%
367.10
Current Assets
543.38
+14.28%
475.48
+45.41%
327.00
-8.40%
357.00
Cash Cash Equivalents And Short Term Investments
530.11
+12.75%
470.17
+47.67%
318.39
-9.53%
351.95
Cash And Cash Equivalents
61.15
+46.76%
41.67
-51.61%
86.10
+291.47%
21.99
Other Short Term Investments
468.96
+9.44%
428.50
+84.46%
232.30
-29.60%
329.95
Prepaid Assets
5.05
Other Current Assets
13.28
+149.88%
5.31
-38.25%
8.60
+70.31%
5.05
Total Non Current Assets
9.22
-18.67%
11.33
-13.07%
13.04
+29.06%
10.10
Net PPE
9.22
-16.74%
11.07
-12.75%
12.69
+28.82%
9.85
Gross PPE
15.99
+1.46%
15.76
+2.95%
15.31
+40.22%
10.92
Accumulated Depreciation
-6.77
-44.48%
-4.68
-79.09%
-2.62
-145.63%
-1.06
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.81
+0.00%
0.81
+3.73%
0.78
+176.87%
0.28
Construction In Progress
0.08
0.00
-100.00%
0.08
-98.91%
7.34
Other Properties
5.46
+2.88%
5.30
-7.27%
5.72
+73.49%
3.30
Leases
9.65
+0.00%
9.65
+10.52%
8.73
0.00
Other Non Current Assets
0.26
-24.71%
0.35
+38.65%
0.25
Total Liabilities Net Minority Interest
30.35
+9.95%
27.60
+30.16%
21.20
+4.02%
20.39
Current Liabilities
27.37
+14.71%
23.86
+42.27%
16.77
+1.12%
16.59
Payables And Accrued Expenses
13.93
+8.73%
12.81
+26.86%
10.10
-15.48%
11.95
Payables
6.01
+7.65%
5.58
+38.61%
4.03
-34.07%
6.11
Accounts Payable
6.01
+7.65%
5.58
+38.61%
4.03
-34.07%
6.11
Current Accrued Expenses
7.92
+9.56%
7.23
+19.07%
6.07
+3.96%
5.84
Pensionand Other Post Retirement Benefit Plans Current
12.43
+23.61%
10.06
+76.58%
5.70
+41.25%
4.03
Current Debt And Capital Lease Obligation
1.01
+1.81%
1.00
+1.63%
0.98
+61.18%
0.61
Current Capital Lease Obligation
1.01
+1.81%
1.00
+1.63%
0.98
+61.18%
0.61
Total Non Current Liabilities Net Minority Interest
2.98
-20.45%
3.74
-15.63%
4.43
+16.68%
3.80
Long Term Debt And Capital Lease Obligation
2.98
-20.45%
3.74
-15.63%
4.43
+16.68%
3.80
Long Term Capital Lease Obligation
2.98
-20.45%
3.74
-15.63%
4.43
+16.68%
3.80
Other Non Current Liabilities
Preferred Securities Outside Stock Equity
Stockholders Equity
522.26
+13.73%
459.22
+44.03%
318.83
-8.04%
346.72
Common Stock Equity
522.26
+13.73%
459.22
+44.03%
318.83
-8.04%
346.72
Capital Stock
0.01
+11.11%
0.01
+28.57%
0.01
+16.67%
0.01
Common Stock
0.01
+11.11%
0.01
+28.57%
0.01
+16.67%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
106.25
+12.03%
94.84
+34.61%
70.45
+11.38%
63.26
Ordinary Shares Number
106.25
+12.03%
94.84
+34.61%
70.45
+11.38%
63.26
Additional Paid In Capital
1,067.94
+27.54%
837.36
+48.60%
563.49
+14.38%
492.67
Retained Earnings
-546.37
-44.32%
-378.58
-54.67%
-244.76
-69.27%
-144.60
Gains Losses Not Affecting Retained Earnings
0.68
+61.19%
0.42
+324.24%
0.10
+107.31%
-1.35
Other Equity Adjustments
0.68
+61.19%
0.42
+324.24%
0.10
+107.31%
-1.35
Total Equity Gross Minority Interest
522.26
+13.73%
459.22
+44.03%
318.83
-8.04%
346.72
Total Capitalization
522.26
+13.73%
459.22
+44.03%
318.83
-8.04%
346.72
Working Capital
516.01
+14.26%
451.62
+45.58%
310.23
-8.87%
340.41
Invested Capital
522.26
+13.73%
459.22
+44.03%
318.83
-8.04%
346.72
Total Debt
3.99
-15.77%
4.74
-12.50%
5.41
+22.82%
4.41
Capital Lease Obligations
3.99
-15.77%
4.74
-12.50%
5.41
+22.82%
4.41
Net Tangible Assets
522.26
+13.73%
459.22
+44.03%
318.83
-8.04%
346.72
Tangible Book Value
522.26
+13.73%
459.22
+44.03%
318.83
-8.04%
346.72
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-143.82
-31.91%
-109.03
-18.58%
-91.95
-74.69%
-52.63
Cash Flow From Continuing Operating Activities
-143.82
-31.91%
-109.03
-18.58%
-91.95
-74.69%
-52.63
Net Income From Continuing Operations
-167.79
-25.40%
-133.81
-33.60%
-100.16
-48.08%
-67.64
Depreciation Amortization Depletion
2.27
-1.05%
2.29
+32.22%
1.73
+221.93%
0.54
Depreciation
2.27
-1.05%
2.29
+32.22%
1.73
+221.93%
0.54
Depreciation And Amortization
2.27
-1.05%
2.29
+32.22%
1.73
+221.93%
0.54
Stock Based Compensation
34.75
+40.63%
24.71
+40.73%
17.56
+60.75%
10.92
Change In Working Capital
-5.37
-152.03%
10.33
+762.05%
-1.56
-138.18%
4.09
Change In Prepaid Assets
-7.96
-341.89%
3.29
+192.65%
-3.55
-144.70%
-1.45
Change In Payables And Accrued Expense
3.34
-54.01%
7.26
+246.02%
2.10
-19.90%
2.62
Change In Accrued Expense
3.06
-44.46%
5.52
+152.12%
2.19
-14.86%
2.57
Change In Payable
0.27
-84.34%
1.74
+1988.04%
-0.09
-295.74%
0.05
Change In Account Payable
0.27
-84.34%
1.74
+1988.04%
-0.09
-295.74%
0.05
Change In Other Working Capital
1.24
Change In Other Current Liabilities
-0.75
-240.00%
-0.22
-111.54%
-0.10
-103.56%
2.92
Investing Cash Flow
-32.79
+82.24%
-184.66
-279.48%
102.89
+245.78%
-70.58
Cash Flow From Continuing Investing Activities
-32.79
+82.24%
-184.66
-279.48%
102.89
+245.78%
-70.58
Net PPE Purchase And Sale
-0.26
+80.49%
-1.31
+77.16%
-5.75
-3.59%
-5.55
Purchase Of PPE
-0.26
+80.49%
-1.31
+77.16%
-5.75
-3.59%
-5.55
Capital Expenditure
-0.26
+80.49%
-1.31
+77.16%
-5.75
-3.59%
-5.55
Net Investment Purchase And Sale
-32.53
+82.26%
-183.34
-268.78%
108.63
+267.04%
-65.03
Purchase Of Investment
-527.23
-10.52%
-477.06
-86.45%
-255.87
+12.49%
-292.39
Sale Of Investment
494.69
+68.43%
293.71
-19.42%
364.50
+60.32%
227.36
Financing Cash Flow
196.09
-21.33%
249.25
+368.82%
53.17
-58.99%
129.64
Cash Flow From Continuing Financing Activities
196.09
-21.33%
249.25
+368.82%
53.17
-58.99%
129.64
Net Common Stock Issuance
187.36
-21.65%
239.15
+354.50%
52.62
-59.26%
129.16
Proceeds From Stock Option Exercised
8.73
-15.84%
10.37
+1354.14%
0.71
-1.66%
0.72
Net Other Financing Charges
-0.26
-58.79%
-0.17
+34.26%
-0.25
Changes In Cash
19.48
+143.85%
-44.43
-169.31%
64.10
+897.42%
6.43
Beginning Cash Position
41.67
-51.61%
86.10
+291.47%
21.99
+41.29%
15.57
End Cash Position
61.15
+46.76%
41.67
-51.61%
86.10
+291.47%
21.99
Free Cash Flow
-144.07
-30.57%
-110.34
-12.95%
-97.69
-67.91%
-58.18
Amortization Of Securities
-7.67
+38.90%
-12.54
-31.82%
-9.52
-1652.67%
-0.54
Common Stock Issuance
187.36
-21.65%
239.15
+354.50%
52.62
-59.26%
129.16
Issuance Of Capital Stock
187.36
-21.65%
239.15
+354.50%
52.62
-59.26%
129.16
Net Preferred Stock Issuance
Preferred Stock Issuance
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category